4DMEDICAL Ltd (ASX: 4DX) Share Price Falls 5.10% as Stock Trades Within Its Daily Range

Anjali Anand

13 August 2026 09:31 PM AEST

4DMEDICAL Ltd (ASX: 4DX) Share Price Falls 5.10% as Stock Trades Within Its Daily Range

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

4DMEDICAL Ltd (ASX: 4DX) shares closed lower during the 13 August 2026 session.
The stock traded within a defined intraday range on above-average volume.
Market capitalisation stood in the multi-billion dollar range at the close.
The one-year performance figure reflects a marked change compared to the prior year.
The Health Care sector index recorded a modest gain for the session.

Overview

4DMEDICAL Ltd, trading under the ticker code 4DX on the Australian Securities Exchange (ASX), is categorised within the S&P/ASX 200 Health Care sector. This article presents a factual, educational summary of the company's share price activity for the Trading session ending 13 August 2026, based solely on figures recorded at market close on that date. It is intended to help readers understand recent price movement and is not a recommendation to buy, sell or hold the stock.

Share Price Movement

Shares of 4DMEDICAL Ltd closed the 13 August 2026 session at $3.91, representing a decrease of 5.10% compared to the previous close. This means the stock's price moved lower over the course of the trading day rather than higher. During the session, the share price fluctuated between an intraday high of $4.14 and an intraday low of $3.90, indicating the range within which buying and selling activity took place. The gap between the day's high and low points to a degree of price movement that occurred within the single session, which is a normal feature of day-to-day Equity trading.

Tracking such daily movement offers a snapshot of short-term sentiment reflected in trading activity, though a single session's change forms only a small part of a company's broader price history.

Trading Volume and Market Capitalisation

Trading volume for 4DMEDICAL Ltd reached 4,334,860 shares during the session, reflecting the number of shares that changed hands between buyers and sellers on 13 August 2026. Volume figures are often referenced alongside price movement, as they indicate the level of market participation behind a given change in price.

At the closing price, the company's Market Capitalisation stood at approximately $2.34 billion. Market capitalisation is calculated by multiplying the current share price by the total number of shares on issue, and it is commonly used as a general indicator of a company's overall size relative to other listed entities.

One-Year Performance

Over the twelve months to 13 August 2026, 4DMEDICAL Ltd shares recorded a change of approximately 697.96%, indicating a substantial increase in the share price compared to where it stood a year earlier. This one-year figure captures the cumulative effect of price movements across the entire period, encompassing both upward and downward sessions, rather than reflecting a steady or uniform trend throughout the year.

Health Care Sector Snapshot

The stock is part of the S&P/ASX 200 Health Care Index (ASX: XHJ), which closed the 13 August 2026 session at 29,014.4 points, up 50.0 points, or 0.17%, from the previous close of 28,964.4 points. During the session, the index moved between a day high of 29,130.7 points and a day low of 28,777.6 points. Over the past 52 weeks, the index has ranged between 21,947.2 points and 45,579.6 points, and it has recorded a decline of 35.29% on a one-year basis. This sector-level movement provides context for the individual performance of health care stocks listed on the exchange, though each company's price behaviour is also shaped by its own trading activity.

Conclusion

In summary, 4DMEDICAL Ltd (ASX: 4DX) shares closed the 13 August 2026 session lower, with the stock trading within a defined intraday range on notable volume. The company's market capitalisation and one-year performance figures, taken together with the broader movement of the S&P/ASX 200 Health Care Index, provide a factual snapshot of where the stock stood at that point in time. Readers seeking to understand share price behaviour should consider such figures as part of a wider body of publicly available information, and this article is intended purely for educational reference rather than as guidance on any Investment decision.

Frequently Asked Questions (FAQs)

FAQs

Q: What was the closing share price of 4DMEDICAL Ltd (ASX: 4DX) on 13 August 2026?

A:The stock closed at $3.91, a decrease of 5.10% from the previous close.

Q: What was the trading volume for 4DX on this date?

A:A total of 4,334,860 shares were traded during the session.

Q: What was the market capitalisation of 4DMEDICAL Ltd at close?

A:The company's market capitalisation stood at approximately $2.34 billion.

Q: How has 4DX performed over the past one year?

A:The share price recorded a change of approximately 697.96% over the trailing twelve-month period.

Q: Which sector index is 4DMEDICAL Ltd part of?

A:The company is part of the S&P/ASX 200 Health Care Index (ASX: XHJ), which closed 0.17% higher on the same day.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.